Apeloa Pharmaceutical Co.,Ltd
000739
Pozycja w akcjach
#4301
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Cena akcji
$3.13
Kapitalizacja rynkowa
$3.62B
Zmiana (1 dzień)
-1.46%
Zmiana (1 rok)
46.52%
Kraj
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategoria
Healthcare
Wskaźnik P/B dla Apeloa Pharmaceutical Co.,Ltd (000739)
Wskaźnik P/B na dzień October 2026 TTM: 4.10
Według najnowszych raportów finansowych i ceny akcji Apeloa Pharmaceutical Co.,Ltd, obecny wskaźnik P/B (TTM) wynosi 4.10. Na koniec 2023 wynosił 2.91.
Historia wskaźnika P/B dla Apeloa Pharmaceutical Co.,Ltd od 2000 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 4.10 | 47.08% |
| 2024 | 2.79 | -4.02% |
| 2023 | 2.91 | -36.30% |
| 2022 | 4.57 | -44.09% |
| 2021 | 8.17 | 30.79% |
| 2020 | 6.25 | 54.03% |
| 2019 | 4.06 | 55.35% |
| 2018 | 2.61 | 6.58% |
| 2017 | 2.45 | -25.52% |
| 2016 | 3.29 | -15.47% |
| 2015 | 3.89 | 8.52% |
| 2014 | 3.59 | 61.94% |
| 2013 | 2.21 | 84.56% |
| 2012 | 1.20 | -71.82% |
| 2011 | 4.26 | 43.16% |
| 2010 | 2.97 | -10.68% |
| 2009 | 3.33 | 131.56% |
| 2008 | 1.44 | -62.40% |
| 2007 | 3.82 | 20.96% |
| 2006 | 3.16 | 103.63% |
| 2005 | 1.55 | -23.64% |
| 2004 | 2.03 | -11.01% |
| 2003 | 2.29 | -41.50% |
| 2002 | 3.91 | -43.69% |
| 2001 | 6.94 | 17.81% |
| 2000 | 5.89 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 22.84% |
IN
|
